THERAPIES - SOMMAIRE SEPTEMBRE OCTOBRE 2023

LE VOL 78 - N°5 - SEPTEMBRE OCTOBRE 2023 EST EN LIGNE

Au sommaire

SPECIAL ISSUE

RECENT ADVANCES IN PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY

Pharmacovigilance

·Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!

Annie Pierre Jonville-Bera, Sophie Gautier, Joëlle Micallef, Nathalie Massy, Marina Atzenhoffer, Aurélie Grandvuillemin, Milou-Daniel Drici, the French Network of Regional Pharmacovigilance Centres

·Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?

Annie Pierre Jonville-Bera, Sophie Gautier, Joëlle Micallef, Nathalie Massy, Marina Atzenhoffer, Milou-Daniel Drici, Aurélie Grandvuillemin, Réseau français des centres régionaux de pharmacovigilance

·COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance

COVID-19 and adenovirus vaccines: French experience of enhanced pharmacovigilance

Nathalie Massy, Marina Atzenhoffer, Charlène Boulay, Pauline-Eva Pecquet, Fanny Ledys, Jean-Luc Cracowski, Kamel Masmoudi, Marion Lepelley, Valérie Gras-Champel

·Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)

Marie-Blanche Valnet-Rabier, Martine Tebacher, Sophie Gautier, Joelle Micallef, Francesco Salvo, Antoine Pariente, Haleh Bagheri

·Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective

Francesco Salvo, Antoine Pariente, Marie Blanche Valnet-Rabier, Milou-Daniel Drici, Clement Cholle, Clement Mathieu, Allison Singier, Haleh Bagheri, Martine Tebacher, Joelle Micallef, Sophie Gautier, French Network of Regional Pharmacovigilance Centers

·French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)

Claire de Canecaude, François Montastruc, Sandrine Bergeron, Paola Sanchez-Pena, Aurélie Grandvuillemin, French Network of Regional Pharmacovigilance Centers

·Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic

Aurélie Grandvuillemin, Fanny Rocher, Marie Blanche Valnet-Rabier, Milou-Daniel Drici, Anne Dautriche, the French Pharmacovigilance Network

·Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022

Kevin Bihan, Lorène Lipszyc, Florian Lemaitre, Anne Dautriche, Sophie Fédrizzi, Marina Atzenhoffer, Aurélie Vitores, Annabelle Page, Bénédicte Lebrun-Vignes

Pharmacoepidemiology

·Pharmacoepidemiology and public decision

Mahmoud Zureik, François Cuenot, Bernard Bégaud

·Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines

Mahmoud Zureik, François Cuenot, Alain Weill, Rosemary Dray-Spira

·Drugs and the elderly: A complex interaction

Bernard Bégaud, Sybille de Germay, Pernelle Noize

·Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?

Antoine Pariente

·Potentially inappropriate medications and polypharmacy in the older population: A nationwide cross-sectional study in France in 2019

Solène Drusch, Mahmoud Zureik, Marie Herr

·Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview

Sophie Billioti de Gage, Hugo Jourdain, David Desplas, Rosemary Dray-Spira

·Impact of coronavirus disease 2019 on contraception use in France

Noémie Roland, Jérôme Drouin, David Desplas, Lise Duranteau, François Cuenot, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik